BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15567293)

  • 1. A novel method for coupling doxorubicin to lactosaminated human albumin by an acid sensitive hydrazone bond: synthesis, characterization and preliminary biological properties of the conjugate.
    Di Stefano G; Lanza M; Kratz F; Merina L; Fiume L
    Eur J Pharm Sci; 2004 Dec; 23(4-5):393-7. PubMed ID: 15567293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy.
    Boga C; Fiume L; Baglioni M; Bertucci C; Farina C; Kratz F; Manerba M; Naldi M; Di Stefano G
    Eur J Pharm Sci; 2009 Oct; 38(3):262-9. PubMed ID: 19695327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coupling of lactose molecules to the carrier protein hinders the spleen and bone marrow uptake of doxorubicin conjugated with human albumin.
    Di Stefano G; Fiume L; Baglioni M; Busi C; Chieco P; Kratz F; Mattioli A
    Eur J Pharm Sci; 2007 Feb; 30(2):136-42. PubMed ID: 17218086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentiation grade.
    Di Stefano G; Fiume L; Baglioni M; Bolondi L; Busi C; Chieco P; Kratz F; Manaresi F; Pariali M
    Liver Int; 2006 Aug; 26(6):726-33. PubMed ID: 16842330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin coupled to lactosaminated albumin: effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats.
    Di Stefano G; Fiume L; Baglioni M; Busi C; Bolondi L; Farina C; Mori F; Chieco P; Pariali M; Kratz F; Molin L; Salmaso S; Caliceti P
    Eur J Pharm Sci; 2008 Feb; 33(2):191-8. PubMed ID: 18201877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and repeat-dose toxicity studies of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin (DOXO-EMCH), an albumin-binding prodrug of the anticancer agent doxorubicin.
    Kratz F; Ehling G; Kauffmann HM; Unger C
    Hum Exp Toxicol; 2007 Jan; 26(1):19-35. PubMed ID: 17334177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drug.
    Fiume L; Baglioni M; Bolondi L; Farina C; Di Stefano G
    Drug Discov Today; 2008 Nov; 13(21-22):1002-9. PubMed ID: 18755287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine.
    Fiume L; Bolondi L; Busi C; Chieco P; Kratz F; Lanza M; Mattioli A; Di Stefano G
    J Hepatol; 2005 Oct; 43(4):645-52. PubMed ID: 16023760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver-targeted doxorubicin: effects on rat regenerating hepatocytes.
    Di Stefano G; Derenzini M; Kratz F; Lanza M; Fiume L
    Liver Int; 2004 Jun; 24(3):246-52. PubMed ID: 15189276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactosaminated human albumin, a hepatotropic carrier of drugs.
    Fiume L; Di Stefano G
    Eur J Pharm Sci; 2010 Jul; 40(4):253-62. PubMed ID: 20403430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I and pharmacokinetic study of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin.
    Unger C; Häring B; Medinger M; Drevs J; Steinbild S; Kratz F; Mross K
    Clin Cancer Res; 2007 Aug; 13(16):4858-66. PubMed ID: 17699865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of 18F-human serum albumin: a simple and efficient protein labeling method with 18F using a hydrazone-formation method.
    Chang YS; Jeong JM; Lee YS; Kim HW; Rai GB; Lee SJ; Lee DS; Chung JK; Lee MC
    Bioconjug Chem; 2005; 16(5):1329-33. PubMed ID: 16173815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of combination therapy schedules of doxorubicin and an acid-sensitive albumin-binding prodrug of doxorubicin in the MIA PaCa-2 pancreatic xenograft model.
    Kratz F; Azab S; Zeisig R; Fichtner I; Warnecke A
    Int J Pharm; 2013 Jan; 441(1-2):499-506. PubMed ID: 23149257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 6-maleimidocaproyl hydrazone derivative of doxorubicin (DOXO-EMCH) is superior to free doxorubicin with respect to cardiotoxicity and mitochondrial damage.
    Lebrecht D; Geist A; Ketelsen UP; Haberstroh J; Setzer B; Kratz F; Walker UA
    Int J Cancer; 2007 Feb; 120(4):927-34. PubMed ID: 17131338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albumin Binding Domain Fusing R/K-X-X-R/K Sequence for Enhancing Tumor Delivery of Doxorubicin.
    Liu L; Zhang C; Li Z; Wang C; Bi J; Yin S; Wang Q; Yu R; Liu Y; Su Z
    Mol Pharm; 2017 Nov; 14(11):3739-3749. PubMed ID: 28950700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles.
    Dreis S; Rothweiler F; Michaelis M; Cinatl J; Kreuter J; Langer K
    Int J Pharm; 2007 Aug; 341(1-2):207-14. PubMed ID: 17478065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver targeting of adenine arabinoside monophosphate (ara-AMP) by coupling to lactosaminated human serum albumin.
    Fiume L; Busi C; Di Stefano G; Mattioli A; Torrani-Cerenzia M; Bonino F; Capra G; De Bernardi W; Ponzetto A; Lavezzo B
    Ital J Gastroenterol; 1995 May; 27(4):189-92. PubMed ID: 8520036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced uptake of lactosaminated human albumin by rat hepatocarcinomas: implications for an improved chemotherapy of primary liver tumors.
    Di Stefano G; Fiume L; Bolondi L; Lanza M; Pariali M; Chieco P
    Liver Int; 2005 Aug; 25(4):854-60. PubMed ID: 15998437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin-binding prodrugs of camptothecin and doxorubicin with an Ala-Leu-Ala-Leu-linker that are cleaved by cathepsin B: synthesis and antitumor efficacy.
    Schmid B; Chung DE; Warnecke A; Fichtner I; Kratz F
    Bioconjug Chem; 2007; 18(3):702-16. PubMed ID: 17378599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of albumin-binding doxorubicin prodrugs that are cleaved by prostate-specific antigen.
    Kratz F; Mansour A; Soltau J; Warnecke A; Fichtner I; Unger C; Drevs J
    Arch Pharm (Weinheim); 2005 Oct; 338(10):462-72. PubMed ID: 16211657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.